Original filing (PDF)20250827153907NAL0019139874001

CHARLES K. PEIRCE, MD, PA

Name: CHARLES K. PEIRCE, MD, PA — CHARLES K. PEIRCE PROFIT SHARING PLAN, Form 5500 (2024)
Creator: CHARLES K. PEIRCE, MD, PA

Form 5500-SF

FILING_RECEIVED

CHARLES K. PEIRCE PROFIT SHARING PLAN

Defined-contribution retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$2.9M

Net assets (EOY)

$2.9M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for CHARLES K. PEIRCE, MD, PA.

Plan sponsor

Name

CHARLES K. PEIRCE, MD, PA

EIN

74-2780710

Address

3201 UNIVERSITY DR. EAST, SUITE 440 · BRYAN, TX · 77802

Phone

(979) 731-8660

Industry

Offices of Physicians· Health Care & Social Assistancesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-08-27

Pension benefit codes

3D · Pre-approved plan (master / prototype / VS)

2E · Profit-sharing

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

—

Trustee phone

—

Small plan (5500-SF) — Schedule H data not available.

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Offices of Physicians plans

CASPER ORTHOPAEDIC ASSOCIATES, P.C.

CASPER ORTHOPAEDIC ASSOCIATES, P.C. CASH BALANCE PLAN

$2.9M · 108 participants

WEST TEXAS DIGESTIVE DISEASE CENTER P.A.

WEST TEXAS DIGESTIVE DISEASE CENTER, PA 401(K) RETIREMENT PLAN & TRUST

$2.9M · 24 participants

CENTRAL TEXAS CHEST CLINIC, P.A.

CENTRAL TEXAS CHEST CLINIC, P.A. 401(K) PLAN

$2.9M · 3 participants

ADVANCED UROLOGIC SURGEONS

ADVANCED UROLOGIC SURGEONS 401(K) PLAN

$2.9M · 10 participants

DIEN VAN PHAM, M.D.